Parallel Advisors LLC Buys 208 Shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO)
Parallel Advisors LLC grew its stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 12.5% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 1,875 shares of the biopharmaceutical company’s stock after acquiring an additional 208 shares during the quarter. Parallel Advisors […]
Parallel Advisors LLC grew its stake in shares of Halozyme Therapeutics, Inc. (NASDAQ:HALO – Free Report) by 12.5% in the first quarter, according to the company in its most recent filing with the SEC. The firm owned 1,875 shares of the biopharmaceutical company’s stock after acquiring an additional 208 shares during the quarter. Parallel Advisors […]
